Optometrists in Hummelstown, PA Accepting Medicare
4 Optometrists found. Showing 1 - 4
 Dr. Frederic W Marotta, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1194 Mae St, Hummelstown, PA 17036 Phone: 717-566-6374 Fax: 717-566-6341 |
Dr. Stephen D Baer, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 29 West Main Street, Hummelstown, PA 17036 Phone: 717-566-3216 Fax: 717-256-0030 |
Dr. Gary Scott Kirman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 29 West Main Street, Hummelstown, PA 17036 Phone: 717-566-3216 Fax: 717-256-0030 |
 Kirman Eye Optometrist Medicare: Medicare Enrolled Practice Location: 29 W Main St, Hummelstown, PA 17036 Phone: 717-566-3216 Fax: 717-256-0030 |
News Archive
Sunrise Senior Living reports revenues of $382.6M for the third quarter of 2009
Sunrise Senior Living, Inc. today reported financial results and operating data for the third quarter of 2009. Sunrise will host a conference call and webcast Monday, November 9, 2009, at 9:00 a.m. ET, to discuss the financial results.
Babies resembling their fathers are healthier
A new study has shown that babies that look like their fathers and spend more time with their fathers are likely to be healthier at their first birthday. The study comes from researchers at the Binghamton University, State University of New York. The paper is titled, "If looks could heal: Child health and paternal investment," and was published in the latest issue of the Journal of Health Economics.
AHA statements recommend best practice scenario to care for patients with heart failure
Treatment for heart failure should take into consideration a patient's social determinants of health - their overall living environment, socio-economic status, as well as the needs of unpaid family caregivers, according to two new scientific statements from the American Heart Association, published simultaneously today in the Association's flagship journal Circulation.
AMT inks agreement with Progenika Biopharma for development of LPLchip
Amsterdam Molecular Therapeutics (AMT) and Progenika Biopharma announced today that the companies have entered into a development and commercialization agreement for LPLchip(TM), a diagnostic tool to rapidly diagnose patients with complete and partial lipoprotein lipase deficiency (LPLD). AMT has developed Glybera(R) as a gene therapy for patients with this disease.
› Verified 3 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Podiatrists